| |
| |
|
| Insider
Information: |
Ciechanover Isaac E. |
| Relationship: |
Chief Executive Office... |
| City: |
Brisbane |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
332,243 |
|
|
Indirect Shares
|
290,687 |
|
|
| Direct
Value |
$230,344 |
|
|
|
Indirect Value
|
$201,533 |
|
|
| Total
Shares |
622,930 |
|
|
| Total
Value |
$431,877 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Atara Biotherapeutics, Inc. |
ATRA |
Chief Executive Office... |
2019-05-30 |
332,243 |
2019-05-30 |
290,687 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
• • – |
2018-09-22 |
4 |
D |
$39.85 |
$3,161,221 |
D/D |
(79,328) |
733,285 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
• • – |
2018-07-09 |
4 |
AS |
$39.88 |
$1,198,006 |
I/I |
(30,000) |
126,078 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
• • – |
2018-07-10 |
4 |
AS |
$39.93 |
$1,137,733 |
I/I |
(28,400) |
97,678 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
• • – |
2018-01-23 |
4 |
AS |
$34.05 |
$859,606 |
D/D |
(24,100) |
325,378 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
• • – |
2019-02-09 |
4 |
D |
$38.49 |
$782,271 |
D/D |
(20,324) |
334,618 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
• • – |
2015-05-15 |
4 |
D |
$37.30 |
$552,077 |
D/D |
(14,801) |
54,707 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
• • – |
2018-01-24 |
4 |
AS |
$33.20 |
$486,938 |
D/D |
(14,400) |
310,978 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
• • – |
2018-02-14 |
4 |
AS |
$45.05 |
$484,956 |
I/I |
(10,000) |
262,878 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
• • – |
2018-02-16 |
4 |
AS |
$45.44 |
$469,670 |
I/I |
(10,000) |
242,878 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
• • – |
2018-02-15 |
4 |
AS |
$45.58 |
$468,789 |
I/I |
(10,000) |
252,878 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
• • – |
2018-02-13 |
4 |
AS |
$45.10 |
$451,000 |
I/I |
(10,000) |
272,878 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
• • – |
2018-01-11 |
4 |
AS |
$21.49 |
$438,900 |
I/I |
(20,000) |
360,178 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
• • – |
2017-03-17 |
4 |
AS |
$18.50 |
$396,576 |
I/I |
(20,000) |
498,178 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
• • – |
2018-02-20 |
4 |
AS |
$45.28 |
$393,936 |
I/I |
(8,700) |
234,178 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
• • – |
2017-12-29 |
4 |
AS |
$18.24 |
$372,628 |
I/I |
(20,000) |
388,778 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
• • – |
2018-01-25 |
4 |
AS |
$33.22 |
$340,976 |
I/I |
(10,000) |
300,978 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
• • – |
2018-01-26 |
4 |
AS |
$35.46 |
$339,558 |
I/I |
(9,300) |
291,678 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
• • – |
2018-01-22 |
4 |
AS |
$30.93 |
$330,735 |
I/I |
(10,000) |
349,478 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
• • – |
2017-03-27 |
4 |
AS |
$20.34 |
$252,216 |
I/I |
(12,400) |
485,778 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
• • – |
2016-04-11 |
4 |
AS |
$20.42 |
$245,244 |
I/I |
(12,010) |
366,011 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
• • – |
2018-05-21 |
4 |
AS |
$51.67 |
$231,441 |
I/I |
(4,400) |
175,678 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
• • – |
2018-05-22 |
4 |
AS |
$50.88 |
$223,872 |
I/I |
(4,400) |
171,278 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
• • – |
2018-06-05 |
4 |
AS |
$49.51 |
$218,756 |
I/I |
(4,400) |
166,878 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
• • – |
2018-06-06 |
4 |
AS |
$46.53 |
$208,532 |
I/I |
(4,400) |
162,478 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
• • – |
2018-02-22 |
4 |
AS |
$42.74 |
$201,832 |
I/I |
(4,600) |
225,078 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
